24,25-iminolanosterol: structure given in first source
ID Source | ID |
---|---|
PubMed CID | 163740 |
CHEMBL ID | 562543 |
SCHEMBL ID | 5024809 |
MeSH ID | M0164652 |
Synonym |
---|
(3s,5r,10s,13r,14r,17r)-17-[(1r)-3-(3,3-dimethylaziridin-2-yl)-1-methyl-propyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol |
24,25-(r,s)-epiminolanosterol |
epiminolanosterol |
CHEMBL562543 |
104960-23-8 |
(3s,5r,10s,13r,14r,17r)-17-[(2r)-4-(3,3-dimethylaziridin-2-yl)butan-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol |
24-norchol-8-en-3-ol, 23-(3,3-dimethyl-2-aziridinyl)-4,4,14-trimethyl-, (3beta,5alpha)- |
24,25-emls |
24,25-iminolanosterol |
SCHEMBL5024809 |
24-norchol-8-en-3-ol, 23-(3,3-dimethyl-2-aziridinyl)-4,4,14-trimethyl-, (3.beta.,5.alpha.)- |
DTXSID101034417 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID432903 | Inhibition of sunflower S-adenosyl-L-methionine-C-24 methyltransferase | 2009 | European journal of medicinal chemistry, Sep, Volume: 44, Issue:9 | Aziridine alkaloids as potential therapeutic agents. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (8.33%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (91.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |